Interview: The Rivelin patch sticks to the mucosal surface for much longer than any other treatment
Though the oral mucosa’s accessibility and high level of blood supply make it an ideal site for drug delivery, various other factors can make drug delivery quite difficult. However, a new polymer plaster, the Rivelin patch, developed by scientists from the University of Sheffield’s School of Clinical Dentistry in collaboration with Dermtreat from Copenhagen in Denmark, has the potential to revolutionise the treatment of oral conditions. Dental Tribune International spoke with Dr Craig Murdoch, Reader in Oral Bioscience at the university and lead author of the research, about how the patch works, its benefits and upcoming plans for clinical trials.